started · updated
Amil sale negotiations advance between Seripieri and Bain, Advent
Negotiations for the sale of 100% of the healthcare operator Amil to US-based private equity firms Bain Capital and Advent International have reached an advanced stage. While reports suggest the deal is nearing final adjustments, a recent meeting between Amil's controller, José Seripieri Filho, and the investment funds did not yield an immediate resolution, leaving certain financial accounts to be recalculated.
A significant hurdle remains the valuation gap, estimated at approximately R$ 2 billion. Seripieri is reportedly seeking a total deal value of around R$ 18 billion, which would cover both the company purchase and the assumption of Amil's existing financial obligations.
In preparation for a potential transition, Bain and Advent have reportedly identified Irlau Machado, the former president of NotreDame Intermédica, as the candidate to lead Amil should the acquisition be finalized.
Entities
Advent International · Amil · Bain Capital · Irlau Machado · José Seripieri Filho
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] Negotiations for the sale of 100% of Amil to Bain Capital and Advent International have reached the final adjustment stage. bpmoney.com.br
- [○ 1 SOURCE] Bain Capital and Advent International have reportedly selected Irlau Machado to lead Amil if the acquisition is completed. bpmoney.com.br
- [○ 1 SOURCE] A recent meeting between Amil's controller and representatives from Bain Capital and Advent did not result in an immediate agreement. blogdomagno.com.br
- [○ 1 SOURCE] José Seripieri Filho seeks a sale price near R$ 18 billion, including the assumption of Amil's financial obligations. bpmoney.com.br
- [○ 1 SOURCE] There is a valuation gap of approximately R$ 2 billion between the seller's asking price and the buyers' offer. bpmoney.com.br